We are live on ! Find out more
GP

Geneva Partners Portfolio holdings

AUM $375M
1-Year Est. Return 131.24%
This Fund
S&P 500
This Quarter Est. Return
+13.2%
1 Year Est. Return
+131.24%
3 Year Est. Return
+400.69%
5 Year Est. Return
+687.84%
10 Year Est. Return
AUM
$189M
AUM Growth
+$25.7M
Cap. Flow
+$9.98M
Cap. Flow %
5.27%
Top 10 Hldgs %
34.39%
Holding
114
New
33
Increased
29
Reduced
30
Closed
21

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$5.78M
2
HON icon
Honeywell
HON
+$4.26M
3
SHOP icon
Shopify
SHOP
+$4.15M
4
CAT icon
Caterpillar
CAT
+$3.58M
5
URI icon
United Rentals
URI
+$3.27M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$5.84M
2
LLY icon
Eli Lilly
LLY
+$4.45M
3
VEEV icon
Veeva Systems
VEEV
+$3.15M
4
DLR icon
Digital Realty Trust
DLR
+$2.81M
5
ZTS icon
Zoetis
ZTS
+$2.32M

Sector Composition

Rank Sector Weight
1 Miscellaneous 22.28%
2 Technology 18.17%
3 Industrials 15.37%
4 Consumer Discretionary 14.96%
5 Communication Services 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
76
NVIDIA
NVDA
$5.12T
$416K 0.22%
31,840
-1,520
-5% -$20.4K
CCJ icon
77
Cameco
CCJ
$39.7B
$408K 0.22%
+30,450
New +$325K
USHY icon
78
iShares Broad USD High Yield Corporate Bond ETF
USHY
$28.2B
$408K 0.22%
9,891
+115
+1% +$4.64K
KSU
79
DELISTED
Kansas City Southern
KSU
$408K 0.22%
2,000
-1,085
-35% -$204K
NAD icon
80
Nuveen Quality Municipal Income Fund
NAD
$2.51B
$407K 0.22%
+26,474
New +$391K
FFTY icon
81
CapForce IBD 50 ETF
FFTY
$74.2M
$399K 0.21%
9,729
+809
+9% +$31.6K
MA icon
82
Mastercard
MA
$502B
$364K 0.19%
1,019
IXJ icon
83
iShares Global Healthcare ETF
IXJ
$4.2B
$361K 0.19%
4,725
-4,044
-46% -$298K
ADM icon
84
Archer Daniels Midland
ADM
$41.7B
$341K 0.18%
+6,771
New +$335K
COUP
85
DELISTED
Coupa Software Incorporated
COUP
$339K 0.18%
+1,000
New +$309K
HYG icon
86
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.1B
$276K 0.15%
3,161
+768
+32% +$65.8K
IWB icon
87
iShares Russell 1000 ETF
IWB
$48.4B
$254K 0.13%
1,201
+26
+2% +$5.19K
HAL icon
88
Halliburton
HAL
$29.7B
$227K 0.12%
+12,000
New +$186K
VOT icon
89
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$18.8B
$221K 0.12%
+1,042
New +$205K
IHI icon
90
iShares US Medical Devices ETF
IHI
$3.26B
$216K 0.11%
3,954
-504
-11% -$26.3K
XLK icon
91
State Street Technology Select Sector SPDR ETF
XLK
$119B
$216K 0.11%
+3,316
New +$202K
QQQ icon
92
Invesco QQQ Trust
QQQ
$474B
$215K 0.11%
+686
New +$201K
ADBE icon
93
Adobe
ADBE
$102B
-763
Closed -$374K
AEM icon
94
Agnico Eagle Mines
AEM
$99.7B
-10,835
Closed -$863K
AKAM icon
95
Akamai
AKAM
$15.1B
-8,370
Closed -$925K
AU icon
96
AngloGold Ashanti
AU
$50.9B
-37,420
Closed -$987K
BABA icon
97
Alibaba
BABA
$272B
-19,869
Closed -$5.84M
BTG icon
98
B2Gold
BTG
$6.9B
-23,000
Closed -$150K
CHGG icon
99
Chegg
CHGG
$82.4M
-19,040
Closed -$1.36M
CRM icon
100
Salesforce
CRM
$210B
-1,765
Closed -$444K

Similar funds

Geneva Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Geneva Partners held 114 positions worth $189M, up 16% from $164M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Geneva Partners deployed $9.98M of net new capital in Q4 2020, opening 33 new positions and adding to 29 existing holdings. Its largest new stake was Starbucks: 60,555 shares worth $6.48M.

By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Zoetis, an estimated $2.32M trimmed.

  • Geneva Partners's largest Q4 2020 buy was Starbucks: 60,555 shares worth $6.48M.
  • Geneva Partners added most to Caterpillar in Q4 2020, an estimated $3.58M increase.
  • Geneva Partners's biggest Q4 2020 reduction was Zoetis, cutting an estimated $2.32M.
  • Geneva Partners fully exited Alibaba in Q4 2020, selling an estimated $5.84M.
  • Geneva Partners's ten largest holdings make up 34% of its $189M portfolio in Q4 2020.
  • Geneva Partners opened 33 new positions and closed 21 in Q4 2020.
  • Geneva Partners's portfolio value rose 16% quarter-over-quarter to $189M.

Based on Geneva Partners's 13F filing for Q4 2020, filed 1 Feb 2021.